Literature DB >> 17717433

Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology.

Alexander R Judkins1.   

Abstract

Immunohistochemical staining for INI1 (BAF47) expression has been recently described. Loss of expression of INI1 as detected by immunohistochemical staining correlates with deletion and mutations of the INI1 gene in patients with malignant rhabdoid tumors and central nervous system atypical teratoid/rhabdoid tumors and as such is a sensitive and specific marker for these tumors. Loss of INI1 expression may rarely be encountered in other tumor types. This article reviews the utility of immunohistochemical staining for INI1 expression.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17717433     DOI： 10.1097/PAP.0b013e3180ca8b08

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN： 1072-4109            Impact factor:   3.875


  25 in total

1.  A rapid progression of disease after surgical excision of a malignant rhabdoid tumor of the bladder.

Authors:  Matthew E Sterling; Christopher J Long; Kristopher R Bosse; Rochelle Bagatell; Aseem R Shukla
Journal:  Urology       Date:  2015-01-09       Impact factor: 2.649

2.  The 2016 World Health Organization Classification of tumours of the Central Nervous System: what the paediatric neuroradiologist needs to know.

Authors:  Sahil Chhabda; Olivia Carney; Felice D'Arco; Thomas S Jacques; Kshitij Mankad
Journal:  Quant Imaging Med Surg       Date:  2016-10

Review 3.  Molecular diagnostics in embryonal brain tumors.

Authors:  Charles G Eberhart
Journal:  Brain Pathol       Date:  2011-01       Impact factor: 6.508

4.  SNF5 as a prognostic factor in skull base chordoma.

Authors:  Mingxuan Li; Yixuan Zhai; Jiwei Bai; Shuai Wang; Hua Gao; Chuzhong Li; Songbai Gui; Jiang Du; Yazhuo Zhang
Journal:  J Neurooncol       Date:  2017-12-08       Impact factor: 4.130

5.  SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.

Authors:  Abbas Agaimy; Arndt Hartmann; Cristina R Antonescu; Simion I Chiosea; Samir K El-Mofty; Helene Geddert; Heinrich Iro; James S Lewis; Bruno Märkl; Stacey E Mills; Marc-Oliver Riener; Thomas Robertson; Ann Sandison; Sabine Semrau; Roderick H W Simpson; Edward Stelow; William H Westra; Justin A Bishop
Journal:  Am J Surg Pathol       Date:  2017-04       Impact factor: 6.394

Review 6.  What is new in epithelioid soft tissue tumors?

Authors:  Abbas Agaimy
Journal:  Virchows Arch       Date:  2019-11-04       Impact factor: 4.064

7.  Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas.

Authors:  Portia A Kreiger; Alexander R Judkins; Pierre A Russo; Jaclyn A Biegel; Brian J Lestini; Chatchawin Assanasen; Bruce R Pawel
Journal:  Mod Pathol       Date:  2008-11-07       Impact factor: 7.842

8.  ERG expression in epithelioid sarcoma: a diagnostic pitfall.

Authors:  Markku Miettinen; Zengfeng Wang; Maarit Sarlomo-Rikala; Ziedulla Abdullaev; Svetlana D Pack; John F Fetsch
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

9.  SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract.

Authors:  Justin A Bishop; Cristina R Antonescu; William H Westra
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

10.  High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system.

Authors:  Theodore Nicolaides; Tarik Tihan; Biljana Horn; Jaclyn Biegel; Michael Prados; Anuradha Banerjee
Journal:  J Neurooncol       Date:  2009-11-22       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.